Citadel Advisors - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$4,040,199
-82.0%
149,859
-88.0%
0.00%
-83.3%
Q3 2022$22,391,000
+39.4%
1,246,705
-3.5%
0.01%
+50.0%
Q2 2022$16,057,000
+37.9%
1,291,796
+47.8%
0.00%
+100.0%
Q1 2022$11,645,000
+34.8%
874,189
+57.5%
0.00%0.0%
Q4 2021$8,640,000
-27.9%
554,920
+3.9%
0.00%0.0%
Q3 2021$11,985,000
+3.0%
534,048
+4.5%
0.00%0.0%
Q2 2021$11,635,000
+7.4%
510,997
-2.9%
0.00%0.0%
Q1 2021$10,835,000
-43.7%
526,481
-24.5%
0.00%
-60.0%
Q4 2020$19,257,000
+310.1%
697,175
+108.6%
0.01%
Q3 2020$4,696,000
-66.9%
334,227
-51.5%
0.00%
-100.0%
Q2 2020$14,206,000
+288.2%
688,951
+42.1%
0.01%
+400.0%
Q1 2020$3,659,000
+13.5%
484,758
+133.4%
0.00%0.0%
Q4 2019$3,224,000
+655.0%
207,723
+152.8%
0.00%
Q3 2019$427,000
-76.0%
82,158
-58.1%
0.00%
-100.0%
Q2 2019$1,776,000196,2450.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 85,000$1,132,0001.20%
Bellevue Group AG 5,859,039$78,042,0000.91%
APIS CAPITAL ADVISORS, LLC 40,000$533,0000.64%
Pier Capital, LLC 294,954$3,929,0000.50%
Resolute Capital Asset Partners LLC 50,000$666,0000.42%
Rhenman & Partners Asset Management AB 249,300$3,321,0000.33%
Hennion & Walsh Asset Management, Inc. 409,079$5,449,0000.29%
TORRAY INVESTMENT PARTNERS LLC 79,868$1,064,0000.17%
PLATINUM INVESTMENT MANAGEMENT LTD 195,211$2,600,0000.08%
DUALITY ADVISERS, LP 54,164$721,0000.08%
View complete list of MYOVANT SCIENCES LTD shareholders